Literature DB >> 2454355

The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.

T Ogihara1, M Ikeda, Y Goto, K Yoshinaga, Y Kumahara, O Iimura, M Ishii, E Murakami, T Takeda, T Kokubu.   

Abstract

The effect of once daily low-dose carvedilol on circadian variations of blood pressure (BP) was studied in Japanese patients with mild or moderate essential hypertension. Thirty-one patients were admitted to hospital whose BP was 150/90 mm Hg/day or greater and they participated in the study. After a placebo period of 1 week, 5 or 10 mg carvedilol was given once daily in the morning for 3 to 7 days, and if BP reduction was not sufficient, the dose was increased to 20 mg daily. The blood pressure variation was monitored before and 1, 2, 4, 6, 8, 10, 12, and 24 h after administration of the drug on the last day of placebo and final dose of carvedilol. Of the 31 cases receiving carvedilol once daily, cumulative effectiveness (13 mm Hg reduction in mean BP) was 48.4% at 10 mg/day and 54.8% at 20 mg/day. Both systolic and diastolic pressures decreased significantly and heart rate decreased slightly. There was no significant difference between the standard deviations of BP on the last days of the control period and the carvedilol treatment. The difference between maximum and minimum BP during the day was not significant between the two periods. Circadian variations of heart rate were also not significantly different for the two periods. This indicates that carvedilol did not have any effect on circadian variations of BP and heart rate. The present study also suggests that low-dose carvedilol once daily may be effective in the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2454355

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.

Authors:  M Kohno; T Takeda; M Ishii; T Saruta; Y Mizuno; M Yoshimura; S Kubo; K Fukiyama; M Fujishima
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Dose-effect relationship of carvedilol in essential hypertension. An open study.

Authors:  T Ogihara; Y Goto; K Yoshinaga; Y Kumahara; O Iimura; M Ishii; E Murakami; T Takeda; T Kokubu; K Arakawa
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.

Authors:  H Hashimoto; M Tanaka; A Kanda; A Akashi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  C J Dunn; A P Lea; A J Wagstaff
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 5.  Drug treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D McTavish; D Campoli-Richards; E M Sorkin
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics and pharmacodynamics of carvedilol.

Authors:  T Morgan
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

8.  The use of carvedilol in elderly hypertensive patients.

Authors:  T O Morgan; A Anderson; J Cripps; W Adam
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.